Investing Profile

Katie Ellias

InvestorVC
Managing Director at T1D Fund
t1dfund.org/our-people/katie-...Boston, Massachusetts
Photo of Katie Ellias, Managing Partner at T1D Fund
Your Intro Paths to Katie Ellias
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Katie Ellias on

cb
Current Investing Position
T1D Fund Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
10

Katie Ellias is on these Sector & Stage Rankings

Katie Ellias's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Veralox Therapeutics
Series UnknownJun 2023$24M
Series AJun 2021$17M
SeedSep 2019$5M
$46M
Co-investors: Ben Scruggs (Hatteras Venture Partners)
Jaguar Gene Therapy
Series UnknownMar 2022
$140M
Co-investors: Il Seok Yoon (Samsung Ventures), Robert Nelsen (ARCH Venture Partners), James Flynn (Deerfield Management)
Biolinq
Series BNov 2021$100M
Series AMar 2019$5M
$110M
Co-investors: Nancy Hong (RiverVest)
DiogenX
SeedJun 2020$5M
$42M
Co-investors: Johannes Zanzinger (Boehringer Ingelheim Venture Fund)
i2o Therapeutics
SeedApr 2020$4M
$4M
Co-investors: Christopher Gagliardi (Sanofi Ventures)
Repertoire Immune Medicines
Series UnknownMar 2020
$210M
Co-investors: Doug Cole (Flagship Ventures)
IMTherapeutics
Series AOct 2019$10M
$10M